Baltimore, Maryland
United States
18
2017-01-17
The entities that hold a legal rights for patent applications filed by inventor Donovan David M.:
David M. Donovan from Baltimore, US has applied for patents for these inventions. The list has both pending applications and granted patents:
Isolated recombinant cDNA
#2 | 2016-04-07Antimicrobial Enzyme Fusions Reduce Resistance and Kill Intracellular Staphylococcus aureus
#3 | 2016-03-31Phage twort endolysin CHAP domain is lytic for
#4 | 2015-11-26Intravitreal Injection of a Chimeric Phage Endolysin Ply187; Protection from Staphylococcus aureus Endophthalmitis
#5 | 2015-09-03Enhanced staphylolytic activity of the bacteriophage vBSauS-philPLA88 virion-associated peptidoglycan hydrolase HydH5: fusions, deletions and synergy with LysH5
#6 | 2014-10-09Triple Acting Antimicrobials That Are Refractory To Resistance Development
#7 | 2014-09-18Peptidoglycan hydrolase antimicrobials for eradicating lactobacilli that contaminate and reduce ethanol yields in biofuel fermentation
#8 | 2014-03-06prophage φSH2 endolysin is lytic for
#9 | 2013-12-19Staphylococcal Phage2638A endolysin amidase domain is lytic for
#10 | 2013-10-03Enhanced antimicrobial lytic activity of a chimeric Ply187 endolysin
#11 | 2013-05-23Enhanced staphylolytic activity of the bacteriophage vBSauS-philPLA88 virion-associated peptidoglycan hydrolase HydH5: fusions, deletions and synergy with LysH5
#12 | 2012-03-01Bacteriophage lytic enzymes as alternative antimicrobials
#13 | 2011-12-29Specific lysis of staphylococcal pathogens by bacteriophage phi11 endolysin
#14 | 2011-09-06Specific lysis of pathogens by bacteriophage phi11 endolysin
#15 | 2010-06-24Triple acting antimicrobials that are refractory to resistance development
#16 | 2010-02-04Creating designer antimicrobials; peptidoglycan hydrolase module shuffling
#17 | 2010-01-28Lys K endolysin is synergistic with lysostaphin against MRSA
#18 | 2009-08-11Nucleic acid encoding endolysin fusion protein
260747 ⎘